Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The tetratricopeptide repeat domain 14 pseudogene (LOC100130618, ENSG00000226636) is a genomic DNA sequence that resembles the protein-coding gene *tetratricopeptide repeat domain 14 (TTC14)* but contains mutations or truncations that prevent the production of a functional protein[4]. Pseudogenes are "genomic DNA sequences similar to normal genes but non-functional; they are regarded as defunct relatives of functional genes" and generally do not encode functional proteins or participate in the typical cellular processes associated with their related functional genes[4]. The TTC14 gene, for comparison, is predicted to enable nucleic acid binding activity and is involved in ectoderm differentiation, but the pseudogene itself lacks all established protein function, druggability, or known biological effect in disease[1][7]. There are no known drugs, disease associations, safety concerns, or biomarker roles for this pseudogene. Its only "function" is as an evolutionary remnant within the human genome.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetratricopeptide repeat domain 14 pseudogene.